Meeting Details

The board meeting started at 2:00 p.m. and concluded at 5:00 p.m. on November 13, 2026.

Trading Window Closure

The trading window was closed from October 1, 2026 and re-opened from November 16, 2026.

Auditor Review

M/s. Bansi S. Mehta & Company, Mumbai, provided Limited Review Reports on both Standalone and Consolidated Unaudited Financial Results. The auditors concluded that nothing came to their attention causing them to believe the statements contain material misstatements or fail to disclose required information under SEBI Listing Regulations.

Financial Results - Standalone (₹ in Lakhs)

Quarter Ended September 30, 2026:

  • Revenue from operations: ₹62,119.01
  • Other Income: ₹1,450.01
  • Total Income: ₹63,569.02
  • Total Expenses: ₹59,680.11
  • Profit before tax: ₹3,888.91
  • Total Tax: ₹1,234.43
  • Net Profit: ₹2,654.48
  • Other Comprehensive Income: ₹190.00
  • Total Comprehensive Income: ₹2,844.48
  • Basic EPS: ₹5.05 (not annualized)
  • Diluted EPS: ₹5.05 (not annualized)

Half Year Ended September 30, 2026:

  • Revenue from operations: ₹119,450.01
  • Other Income: ₹2,813.00
  • Total Income: ₹122,263.01
  • Total Expenses: ₹115,143.56
  • Profit before tax: ₹7,119.45
  • Total Tax: ₹2,101.62
  • Net Profit: ₹5,017.83
  • Other Comprehensive Income: ₹190.00
  • Total Comprehensive Income: ₹5,207.83
  • Basic EPS: ₹9.57 (not annualized)
  • Diluted EPS: ₹9.57 (not annualized)

Financial Results - Consolidated (₹ in Lakhs)

Quarter Ended September 30, 2026:

  • Revenue from operations: ₹62,119.01
  • Other Income: ₹1,450.01
  • Total Income: ₹63,569.02
  • Total Expenses: ₹59,686.20
  • Profit before tax: ₹3,882.82
  • Total Tax: ₹1,234.43
  • Net Profit: ₹2,648.39
  • Other Comprehensive Income: ₹190.00
  • Total Comprehensive Income: ₹2,838.39
  • Basic EPS: ₹5.05 (not annualized)
  • Diluted EPS: ₹5.05 (not annualized)

Half Year Ended September 30, 2026:

  • Revenue from operations: ₹119,450.01
  • Other Income: ₹2,813.00
  • Total Income: ₹122,263.01
  • Total Expenses: ₹115,149.45
  • Profit before tax: ₹7,113.56
  • Total Tax: ₹2,101.62
  • Net Profit: ₹5,011.94
  • Other Comprehensive Income: ₹190.00
  • Total Comprehensive Income: ₹5,201.94
  • Basic EPS: ₹9.57 (not annualized)
  • Diluted EPS: ₹9.57 (not annualized)

Comparative Figures (Standalone)

Quarter Ended September 30, 2025:

  • Revenue from operations: ₹55,856.01
  • Net Profit: ₹2,058.61
  • Basic EPS: ₹3.68

Half Year Ended September 30, 2025:

  • Revenue from operations: ₹106,393.21
  • Net Profit: ₹2,951.21
  • Basic EPS: ₹5.28

Capital Structure

  • Paid up Equity Share capital: ₹558.56 lakhs (Face Value ₹10 each)
  • Other Equity (Standalone): ₹76,187.53 lakhs as of March 31, 2026
  • Other Equity (Consolidated): ₹76,185.59 lakhs as of March 31, 2026

Segment Information

The Company is engaged in the business of manufacturing of "Chemicals", which is the only Operating Segment as per Ind AS 108.

Subsidiary Information

Consolidated Financial Results include results of wholly owned subsidiary Transpek Creative Chemistry Private Limited.

Assets and Liabilities Position (Standalone as of September 30, 2026)

  • Total Assets: ₹109,206.97 lakhs
  • Non-current Assets: ₹68,996.26 lakhs
  • Current Assets: ₹40,210.71 lakhs
  • Total Equity: ₹76,746.09 lakhs
  • Non-current Liabilities: ₹9,765.34 lakhs
  • Current Liabilities: ₹19,764.27 lakhs

Cash Flow Statement (Standalone Half Year Ended September 30, 2026)

  • Net Cash from Operating Activities: ₹4,890.82 lakhs
  • Net Cash used in Investing Activities: ₹(3,582.14) lakhs
  • Net Cash from Financing Activities: ₹920.28 lakhs
  • Net Increase in Cash and Cash Equivalents: ₹(3,770.64) lakhs
  • Cash and Cash Equivalents at period end: ₹2,610.05 lakhs